Capitol Health Ltd (ASX: CAJ) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Capitol Health Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $428.24 million
P/E Ratio 36.23
Dividend Yield 2.44%
Shares Outstanding 1.03 billion
Earnings per share 0.004
Dividend per share 0.01
Year To Date Return 50.91%
Earnings Yield 2.76%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Capitol Health Ltd (ASX: CAJ)
Latest News

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
04 Mar 2021 $0.0050 100.00% Interim 01 Apr 2021
24 Sep 2020 $0.0050 100.00% Final 23 Oct 2020
05 Mar 2020 $0.0050 100.00% Interim 23 Oct 2020
24 Sep 2019 $0.0050 100.00% Final 23 Oct 2019
05 Mar 2019 $0.0050 100.00% Interim 03 Apr 2019
26 Sep 2018 $0.0040 100.00% Final 25 Oct 2018
02 Mar 2018 $0.0040 100.00% Interim 03 Apr 2018
23 Sep 2015 $0.0065 100.00% 23 Oct 2015
25 Mar 2015 $0.0060 100.00% 24 Apr 2015
24 Sep 2014 $0.0050 100.00% Final 24 Oct 2014
24 Mar 2014 $0.0040 100.00% Interim 24 Apr 2014
23 Sep 2013 $0.0030 100.00% Final 25 Oct 2013
22 Mar 2013 $0.0025 100.00% Interim 26 Apr 2013
24 Sep 2012 $0.0020 100.00% Final 19 Oct 2012
04 Apr 2012 $0.0020 100.00% Interim 20 Apr 2012

CAJ ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Capitol Health Ltd

Capitol Health Ltd is a provider of diagnostic imaging and related services to the Australian healthcare market. The firm has one business segment which is the operation of diagnostic imaging facilities in Australia. Geographically, it operates only in Australia. It generates its revenue from diagnostic imaging services. The company's offerings include X-Ray, Ultrasound, CT and MRIs, nuclear medicine, mammography/breast screen, bone densitometry, and other related services.

CAJ Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
16 Sep 2021 $0.42 $0.01 2.44% 394,662 $0.41 $0.42 $0.41
15 Sep 2021 $0.41 $0.00 0.00% 490,003 $0.42 $0.42 $0.41
14 Sep 2021 $0.41 $-0.01 -2.41% 758,724 $0.42 $0.42 $0.41
13 Sep 2021 $0.42 $0.01 2.44% 406,980 $0.42 $0.42 $0.42
10 Sep 2021 $0.41 $-0.01 -2.38% 307,396 $0.42 $0.42 $0.41
09 Sep 2021 $0.42 $-0.01 -2.35% 1,672,336 $0.43 $0.43 $0.41
08 Sep 2021 $0.43 $0.04 10.26% 3,121,566 $0.38 $0.43 $0.38
07 Sep 2021 $0.39 $0.00 0.00% 1,137,833 $0.39 $0.39 $0.38
06 Sep 2021 $0.39 $0.02 5.41% 700,960 $0.38 $0.39 $0.37
03 Sep 2021 $0.37 $-0.02 -5.19% 144,207 $0.39 $0.39 $0.37
02 Sep 2021 $0.39 $0.03 8.33% 877,707 $0.36 $0.39 $0.36
01 Sep 2021 $0.36 $-0.02 -5.33% 427,082 $0.37 $0.37 $0.36
31 Aug 2021 $0.38 $0.00 0.00% 659,721 $0.37 $0.38 $0.36
30 Aug 2021 $0.38 $-0.01 -2.63% 4,973,406 $0.38 $0.39 $0.36
27 Aug 2021 $0.38 $-0.02 -5.00% 4,533,135 $0.40 $0.40 $0.38
26 Aug 2021 $0.40 $-0.02 -4.82% 1,639,422 $0.42 $0.43 $0.39
25 Aug 2021 $0.42 $0.02 5.00% 821,152 $0.40 $0.42 $0.40
24 Aug 2021 $0.40 $0.02 5.19% 1,068,749 $0.40 $0.41 $0.39
23 Aug 2021 $0.39 $0.00 0.00% 334,483 $0.39 $0.40 $0.38
20 Aug 2021 $0.39 $0.01 2.63% 932,691 $0.38 $0.39 $0.38
19 Aug 2021 $0.38 $-0.01 -2.60% 1,831,535 $0.39 $0.39 $0.37
18 Aug 2021 $0.39 $-0.01 -2.56% 207,898 $0.39 $0.39 $0.38
17 Aug 2021 $0.39 $0.00 0.00% 1,150,737 $0.39 $0.40 $0.37

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
17 Nov 2020 Justin Walter Issued 2 $830,508
Issue of securities. 5,351,382 - Performance Rights

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Andrew Demetriou Non-Executive ChairmanNon-Executive Director Nov 2014
Mr Demetriou was Chief Executive Officer of the Australian Football League from 2003 until June 2014 and has been the Managing Director of the Ruthinium Group (of which he remains a board member). He has also served as Non-Executive Chairman of the Baxter Group, is a former Chairman of the Australian Multicultural Advisory Council and served 2 years on the Referendum Council on behalf of the Federal Government for Recognition in the Constitution. He is also currently Chairman of Board of Management, Cox Architecture. He is also a member of the Risk Committee.
Mr Justin Samuel Walter Chief Executive OfficerManaging Director Jul 2019
Mr Walter brings with him thirty years wealth of experience in healthcare across public and private hospitals, GP and allied health clinics, and having consult along with management and leadership skills. He has held senior roles managing hospitals for Healthscope, and Group's health sector.
Ms Laura Nicole McBain Non-Executive Director Jul 2021
Ms McBain was the CEO and Managing Director of ASX listed Bellamys Australia Ltd from 2014 to 2017, prior to which she was CEO / General Manager since 2007. Prior to joining Bellamys, Laura practiced as an accountant in both Sydney and Tasmania. Laura was also the Managing Director of Maggie Beer Holdings from 2017 to 2019 and former Non-Executive Director of Export Finance Australia from 2014 to 2020. She is currently a Strategic Consultant for the food and formula industry, and a Non-Executive Director for ASX listed Lark Distilling Ltd (ASX: LRK). In 2013, Laura was named Telstra Tasmanian Businesswoman of the Year and went on to be named the Telstra Australian Business Woman of the Year for 2013 (Private and Corporate).
Ms Nicole Sheffield Non-Executive Director Dec 2015
Ms Sheffield is Executive General Manager Community & Consumer at Australia Post in charge for delivering experiences across more than 4,300 Post Offices - Australia's retail network - the customer contact centre and digital channels, as well as brand, marketing, community and corporate social responsibility. Ms Sheffield's understanding was previously Chief Digital Officer for News Corp Australia and Chief Executive of NewsLifeMedia, leading the lifestyle publishing division. He is also a member of the Risk Committee.
Mr Richard John Loveridge Non-Executive Director Sep 2017
Mr Loveridge served as a partner in the Corporate Group of Herbert Smith Freehills for more than 20 years and was Managing Partner of their National Corporate Group for 5 years. Mr Loveridge's experience includes capital raisings, mergers and acquisitions, joint ventures, shareholder agreements, company reorganisations, and corporate head office and advisory matters. He was admitted as a Barrister and Solicitor to the Supreme Court of Victoria in 1988 and is also a council member of Scotch College in Melbourne and a director of Diabetes Victoria. He is also a chairman of the Risk Committee.
Dr Kevin (Kai-Chung) Shaw Non-Executive Director Sep 2021
Dr Shaw has training and experience in neuroradiology and musculoskeletal imaging. He is the current Director of Radiology and Nuclear Medicine atthe University Hospital, Barwon Health. He has completed his radiology training at Royal Melbourne Hospital. Dr Shaw is a Clinical Associate Professor at Deakin Medical School and holds an honorary position with University of Melbourne where he participates in the Victorian radiology registrar teaching program. He is a past examiner for the Royal Australian and New Zealand College of Radiologists (RANZCR) and previously sat on the College's Anatomy Exam Review Panel. He has been an MRI Clinical Reviewer for the College since 2014. Dr Shaw currently sits on the Barwon Health, Medical Advisory Committee, Technology / Clinical Practice Committee and Mortality Committee. He is a councillor for Australian Medical Association Victoria as the State Representative for RANZCR.
Ms Melanie Jaye Leydin Company Secretary Aug 2017
-
Marcell Judkins Chief Financial Officer
-
Melanie Jaye Leydin Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Hsbc Custody Nominees (Australia) Limited 169,215,138 16.55%
J P Morgan Nominees Australia Pty Limited 146,856,074 14.36%
National Nominees Limited 128,075,245 12.52%
Citicorp Nominees Pty Limited 70,051,794 6.85%
BNP Paribas Nominees Pty Ltd <Agency Lending Drp A/C> 58,337,814 5.70%
BNP Paribas Noms Pty Ltd <Drp> 36,628,828 3.58%
Ubs Nominees Pty Ltd 35,918,686 3.51%
Idinoc Pty Ltd <J & R Conidi Family A/C> 27,477,886 2.69%
HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 21,389,242 2.09%
Neweconomy Com Au Nominees Pty Limited <900 Account> 12,794,938 1.25%
Nick Conidi Pty Ltd <Conidi Family A/C> 11,764,740 1.15%
Gia Chau Pty Ltd 11,200,000 1.10%
SMKA Super Pty Ltd <SK Super Fund A/C> 6,901,313 0.67%
CS Third Nominees Pty Limited <Hsbc Cust Nom Au Ltd 13 A/C> 6,430,839 0.63%
Stelhaven SMSF Pty Ltd <Stelhaven Super Fund A/C> 6,320,843 0.62%
Mr Nicola Conidi + Mrs Giannina Conidi <Nick & Jan Conidi S/F A/C> 6,160,486 0.60%
Teleah Pty Ltd <JR Sauvey Super Fund A/C> 4,177,946 0.41%
Mr Andrew Duncan Harrison + Mrs Katrina Ellen Harrison <Harrison Super Fund A/C> 3,626,818 0.35%
Dr Jeffrey Eric Dale Chick + Dr Pamela Hazel Chick 3,410,000 0.33%
Julsan Pty Ltd <Ponte Super Fund A/C> 3,133,740 0.31%

Profile

since

Note